Study on the effect of histone deacetylase gene polymorphism and environmental factors on type 2 diabetes mellitus
-
摘要:
目的 探讨组蛋白去乙酰化酶(histone deacetylase, HDACs)的3个单核苷酸多态性位点与2型糖尿病(type 2 diabetes mellitus, T2DM)的关联, 以及各位点与环境间交互作用对T2DM易感性的影响, 为T2DM预防和治疗提供依据。 方法 2017年在广州市花都区17个行政村和2个社区居委中随机抽取10个村做基线调查后选取T2DM者为病例组, 以同性别、年龄相差不超过5岁和来源于同一行政村为条件, 1:1个体匹配方法匹配对照组。采用条件Logistic回归分析模型分析基因和环境及其交互作用对T2DM的影响。 结果 共调查499名病例, 平均年龄(61.53±13.08)岁, 男性占37.88%;499名对照的平均年龄(61.48±13.09)岁, 男性占37.88%。甘油三酯(triglyceride, TG)异常(OR=2.410, 95% CI:1.755~3.310, P < 0.001)和总胆固醇(total cholesterol, TC)异常(OR=1.436, 95% CI:1.046~1.972, P=0.025)是T2DM的危险因素。rs72792338 TT+TC基因型携带(OR=0.526, 95% CI:0.349~0.793, P=0.002)是T2DM的保护因素。 结论 甘油三酯和总胆固醇异常是T2DM的危险因素, rs72792338 TT和TC基因型携带是T2DM的保护因素, 未发现HDACs基因与环境对T2DM的影响存在交互作用。 Abstract:Objective To examine whether polymorphisms of histone deacetylase(HDACs) and environment factors can be implicated in type 2 diabetes mellitus(T2 DM), and to provide evidence for the prevention and treatment of T2 DM. Methods In 2017, T2 DM patients and controls were selected from 17 villages in Huadu District, Guangzhou. According the Diagnostic criteria for T2 DM, the case group of T2 DM was matched with control group from the population diagnosed as normal by gender, age no more than 5 years old, and from the same natural village. Conditional logistic regression model was used to analyze the effect of gene and environment and their interaction on T2 DM. Results The average age of 499 cases group were(61.53±13.08) years old, and the average age of 499 controls group were(61.48±13.09) years old. There were no statistic difference between two groups. Furthermore, the two groups were gender-balanced too. In conditional logistic regression model, we found that glycerin trilaurate(TG) abnormalities(OR=2.410, 95% CI: 1.755-3.310, P < 0.001) and cholesterol total(TC) abnormalities(OR=1.436, 95% CI: 1.046-1.972, P=0.025) were risk factors for T2 DM. The subjects carries rs72792338 TC+TT genotype(OR=0.526, 95% CI: 0.349-0.793, P=0.002) had lower the risk to develop T2 DM. Conclusions Abnormal TG and TC are risk factors for T2 DM. Rs72792338 TT and TC genotype carryings decrease the risk of T2 DM. -
Key words:
- Type 2 diabetes mellitus /
- Histone deacetylase /
- Interaction
-
表 1 遗传变异基本信息
Table 1. Information of genetic variation
位点 基因 等位基因 最小等位基因频率 功能区 Haploreg-eQTL Regulome-DB评分 rs72792338 HDAC3 C > T 0.040 intron - 3a rs14251 HDAC3 C > T 0.117 Missense √ 5 rs113045253 SIRT1 C > T 0.131 intron - 3a 表 2 T2DM影响因素单因素条件Logistic回归分析[n(%)]
Table 2. 2 Conditional Logistic regression analysis of single-factor for the influencing factor of T2DM[ n(%)]
因素 病例组 对照组 OR(95% CI)值 P值 BMI(kg/m2) 正常 300(60.12) 334(66.93) 消瘦 10(2.00) 23(4.61) 0.443(0.194~1.012) 0.054 超重 141(28.26) 103(20.64) 1.674(1.204~2.327) 0.002 肥胖 48(9.62) 39(7.82) 1.427(0.888~2.293) 0.142 吸烟 否 414(82.97) 400(80.16) 是 85(17.03) 99(19.84) 0.754(0.508~1.121) 0.163 饮酒 否 450(90.18) 441(88.38) 是 49(9.82) 58(11.62) 0.804(0.522~1.240) 0.324 高血压 否 282(56.51) 310(62.12) 是 217(43.49) 189(37.88) 1.368(1.018~1.839) 0.038 TC 正常 348(69.74) 387(77.56) 异常 151(30.26) 112(22.44) 1.557(1.153~2.102) 0.004 TG 正常 336(67.33) 417(83.57) 异常 163(32.67) 82(16.43) 2.446(1.793~3.338) < 0.001 rs72792338 CC 456(91.38) 426(85.37) TC 38(7.62) 58 (11.62) 0.627(0.411~0.954) 0.029 TT 5(1.00) 15 (3.01) 0.317(0.115~0.874) 0.027 显性模型 - - 0.565(0.382~0.837) 0.004 隐性模型 - - 0.333(0.121~0.917) 0.033 加性模型 - - 0.600(0.432~0.833) 0.002 rs113045253 CC 383(76.76) 374(74.95) AC 108(21.64) 116(23.25) 0.914(0.684~1.221) 0.543 AA 8(1.60) 9 (1.80) 0.870(0.335~2.261) 0.775 显性模型 - - 0.911(0.687~1.208) 0.517 隐性模型 - - 0.889(0.343~2.304) 0.809 加性模型 - - 0.919(0.712~1.186) 0.515 rs14251 CC 398(79.76) 400(80.16) AC 94(18.84) 92(18.44) 1.025(0.752~1.399) 0.874 AA 7(1.40) 7 (1.40) 1.006(0.324~3.128) 0.991 显性模型 - - 1.024(0.756~1.389) 0.877 隐性模型 - - 1.000(0.323~3.101) 1.000 加性模型 - - 1.021(0.771~1.350) 0.886 表 3 T2DM影响因素多因素条件logistic回归分析
Table 3. 3 Analysis of multivariate conditional logistic regression for influencing factors on T2DM
影响因素 β值 Sx Wald χ2值 OR(95% CI)值 P值 TG 正常 1.000 异常 0.879 0.162 29.545 2.410(1.755~3.310) < 0.001 TC 正常 1.000 异常 0.362 0.162 4.996 1.436(1.046~1.972) 0.025 rs72792338显性模型 CC 1.000 TC+TT -0.643 0.210 9.413 0.526(0.349~0.793) 0.002 表 4 rs72792338和TG, rs72792338和TC对T2DM影响的交互作用分析
Table 4. Analysis of interaction on T2DM between rs72792338 and TG, rs72792338 and TC
影响因素 cOR(95% CI)值 P值 OR(95% CI)值a P值a rs72792338显性模型 0.603(0.376~0.966) 0.035 0.583(0.362~0.941) 0.027 TG 2.664(1.895~3.745) < 0.001 2.312(1.620~3.301) < 0.001 rs72792338显性模型×TG 0.624(0.242~1.608) 0.329 0.634(0.241~1.667) 0.356 rs72792338显性模型 0.557(0.342~0.906) 0.019 0.506(0.305~0.837) 0.008 TC 1.582(1.149~2.180) 0.005 1.387(0.985~1.954) 0.061 rs72792338显性模型×TC 0.989(0.415~2.354) 0.980 1.080(0.432~2.695) 0.870 注:a表示调整了BMI、血压、TC(或TG)、吸烟和饮酒。 表 5 基因-基因对T2DM影响的交互作用分析
Table 5. Analysis of interaction between gene and gene on T2DM
因素1 因素2 病例(人) 对照(人) OR(95% CI)值 RERI(95% CI)值 OR(95% CI)值a RERI(95% CI)值a rs72792338 rs113045253 0.043(-0.499~0.585) -0.009(-0.553~0.534) - - 365 344 1.000 1.000 + - 18 30 0.564(0.356~0.896) 0.525(0.323~0.851) - + 30 54 0.938(0.692~1.273) 0.980(0.711~1.352) + + 86 71 0.546(0.267~1.114) 0.496(0.234~1.052) rs72792338 rs14251 -0.088(-0.731~0.554) -0.135(-0.720~0.451) - - 361 338 1.000 1.000 + - 37 62 0.577(0.378~0.879) 0.539(0.345~0.843) - + 95 88 1.023(0.743~1.408) 1.010(0.720~1.416) + + 6 11 0.511(0.188~1.393) 0.415(0.149~1.156) rs14251 rs113045253 0.535(-0.316~1.386) 0.586(-0.352~1.524) - - 307 294 1.000 1.000 + - 76 80 0.911(0.645~1.287) 0.873(0.605~1.261) - + 91 106 0.826(0.602~1.133) 0.875(0.623~1.228) + + 25 19 1.272(0.686~2.359) 1.334(0.694~2.562) 注:-表示野生纯合型, +表示突变基因携带; a表示调整了BMI、血压、吸烟、饮酒、TC、TG和rs72792338显性模型。 -
[1] 杨雪琛, 东梅, 王倩.组蛋白去乙酰化酶和糖尿病相关性研究进展[J].中国糖尿病杂志, 2015, 23(11): 1050-1052. DOI: 10.3969/j.iddn.1006-6187.2015.11.023.Yang XC, Dong M, Wang Q. Research progress of the correlation between histone deacetylases and diabetes mellitus[J]. Chin J Diabetes, 2015, 23(11): 1050-1052. DOI: 10.3969/j.iddn.1006-6187.2015.11.023. [2] 曾转萍. HDAC、SIRT1基因多态性及环境因素与2型糖尿病关系的病例对照研究[D].广州: 南方医科大学, 2014. DOI: 10.7666/d.Y2617902.ZengZP.AssociationsbetweenpolymorphismsofHDAC, SIRT1andenvironmentalfactorsinpatientswithtype2diabetesmellitus[D].Guangzhou: SouthernMedicalUniversity, 2014. DOI: 10.7666/d.Y2617902. [3] 中华医学会糖尿病学分会.中国2型糖尿病防治指南(2017年版)[J].中国实用内科杂志, 2018, 38(4): 292-344. DOI: 10.19538/j.nk2018040108.Chinese Diabetes Society. Guidelines for the prevention and control of type 2 diabetes in China(2017 Edition)[J]. Chin J of Practical Internal Med, 2018, 38(4): 292-344. DOI: 10.19538/j.nk2018040108. [4] 王增武, 范国辉, 张林峰, 等.北方农村地区男性代谢综合征与饮酒关系研究[J].中华疾病控制杂志, 2015, 19(4): 348-351. DOI: 10.16462/j.cnki.zhjbkz.2015.04.008.Wang ZW, Fan GH, Zang LF, et al. Association study between metabolic syndrome and alcohol consumption among rural male residents in northern China[J]. Chin J Dis Control Prev, 2015, 19(4): 348-351. DOI: 10.16462/j.cnki.zhjbkz.2015.04.008. [5] Mihaylova MM, Vasquez DS, Ravnskjaer K, et al. Class IIa histone deacetylases are hormone-activated regulators of FOXO and mammalian glucose homeostasis[J]. Cell, 2011, 145(4): 607-621. DOI: 10.1016/j.cell.2011.03.043. [6] Jolma A, Yan J, Whitington T, et al. DNA-binding specificities of human transcription factors[J]. Cell, 2013, 152(1-2): 327-339. DOI: 10.1016/j.cell.2012.12.009. [7] Knutson SK, Chyla BJ, Amann JM, et al. Liver-specific deletion of histone deacetylase 3 disrupts metabolic transcriptional networks[J]. EMBO J, 2008, 27(7): 1017-1028. DOI: 10.1038/emboj.2008.51. [8] Galmozzi A, Mitro N, Ferrari A, et al. Inhibition of class I histone deacetylases unveils a mitochondrial signature and enhances oxidative metabolism in skeletal muscle and adipose tissue[J]. Diabetes, 2013, 62(3): 732-742. DOI: 10.2337/db12-0548. [9] Grimes JA, Nielsen SJ, Battaglioli E, et al. The co-repressor mSin3A is a functional component of the REST-CoREST repressor complex[J]. J Biol Chem, 2000, 275(13): 9461-9467. DOI: 10.1074/jbc.275.13.9461. [10] Zhang L, Curhan GC, Hu FB, et al. Association between passsive and active smoking and incident type 2 diabetes in women[J]. Diabetes Care, 2011, 34(4): 892-897. DOI: 10.2337/dc10-2087. [11] Tsai AC, Lee SH. Determinants of new-onset diabetes in older adults-Results of a national cohort study[J]. Clin Nutr, 2015, 34(5): 937-942. DOI: 10.1016/j.clnu.2014.09.021.